Pyrosequencing to resolve discrepant Xpert MTB/RIF and mycobacterial growth indicator tube 960

Kanchan Ajbani, Mubin Kazi, Jeffrey Tornheim, Swapna Naik, Rajeev Soman, Anjali Shetty, Camilla Rodrigues

Research output: Contribution to journalArticle

Abstract

Delayed diagnosis of drug resistance has been a major obstacle to proper management and control of drug-resistant tuberculosis (TB). Expanded access to rapid molecular diagnostics such as Xpert MTB/RIF has been helpful, but has generated confusion about how to interpret genotype-phenotype discordance. Optimal management is not clearly defined for patients with rifampin resistance by Xpert MTB/RIF but rifampin susceptibility by phenotypic testing. To resolve this discrepancy, we performed pyrosequencing of discordant isolates identified at a reference laboratory over a 6-month period. We present here strategies to address genotype-phenotype discordance using sequencing.

Original languageEnglish (US)
Pages (from-to)168-170
Number of pages3
JournalLung India
Volume35
Issue number2
DOIs
StatePublished - Mar 1 2018

Fingerprint

Rifampin
Genotype
Phenotype
Multidrug-Resistant Tuberculosis
Molecular Pathology
Delayed Diagnosis
Growth
Drug Resistance

Keywords

  • Culture
  • Discrepancy
  • Pyrosequencing
  • Xpert

ASJC Scopus subject areas

  • Pulmonary and Respiratory Medicine

Cite this

Pyrosequencing to resolve discrepant Xpert MTB/RIF and mycobacterial growth indicator tube 960. / Ajbani, Kanchan; Kazi, Mubin; Tornheim, Jeffrey; Naik, Swapna; Soman, Rajeev; Shetty, Anjali; Rodrigues, Camilla.

In: Lung India, Vol. 35, No. 2, 01.03.2018, p. 168-170.

Research output: Contribution to journalArticle

Ajbani, Kanchan ; Kazi, Mubin ; Tornheim, Jeffrey ; Naik, Swapna ; Soman, Rajeev ; Shetty, Anjali ; Rodrigues, Camilla. / Pyrosequencing to resolve discrepant Xpert MTB/RIF and mycobacterial growth indicator tube 960. In: Lung India. 2018 ; Vol. 35, No. 2. pp. 168-170.
@article{05b65419dc744e2eb588298400568579,
title = "Pyrosequencing to resolve discrepant Xpert MTB/RIF and mycobacterial growth indicator tube 960",
abstract = "Delayed diagnosis of drug resistance has been a major obstacle to proper management and control of drug-resistant tuberculosis (TB). Expanded access to rapid molecular diagnostics such as Xpert MTB/RIF has been helpful, but has generated confusion about how to interpret genotype-phenotype discordance. Optimal management is not clearly defined for patients with rifampin resistance by Xpert MTB/RIF but rifampin susceptibility by phenotypic testing. To resolve this discrepancy, we performed pyrosequencing of discordant isolates identified at a reference laboratory over a 6-month period. We present here strategies to address genotype-phenotype discordance using sequencing.",
keywords = "Culture, Discrepancy, Pyrosequencing, Xpert",
author = "Kanchan Ajbani and Mubin Kazi and Jeffrey Tornheim and Swapna Naik and Rajeev Soman and Anjali Shetty and Camilla Rodrigues",
year = "2018",
month = "3",
day = "1",
doi = "10.4103/lungindia.lungindia_71_17",
language = "English (US)",
volume = "35",
pages = "168--170",
journal = "Lung India",
issn = "0970-2113",
publisher = "Medknow Publications and Media Pvt. Ltd",
number = "2",

}

TY - JOUR

T1 - Pyrosequencing to resolve discrepant Xpert MTB/RIF and mycobacterial growth indicator tube 960

AU - Ajbani, Kanchan

AU - Kazi, Mubin

AU - Tornheim, Jeffrey

AU - Naik, Swapna

AU - Soman, Rajeev

AU - Shetty, Anjali

AU - Rodrigues, Camilla

PY - 2018/3/1

Y1 - 2018/3/1

N2 - Delayed diagnosis of drug resistance has been a major obstacle to proper management and control of drug-resistant tuberculosis (TB). Expanded access to rapid molecular diagnostics such as Xpert MTB/RIF has been helpful, but has generated confusion about how to interpret genotype-phenotype discordance. Optimal management is not clearly defined for patients with rifampin resistance by Xpert MTB/RIF but rifampin susceptibility by phenotypic testing. To resolve this discrepancy, we performed pyrosequencing of discordant isolates identified at a reference laboratory over a 6-month period. We present here strategies to address genotype-phenotype discordance using sequencing.

AB - Delayed diagnosis of drug resistance has been a major obstacle to proper management and control of drug-resistant tuberculosis (TB). Expanded access to rapid molecular diagnostics such as Xpert MTB/RIF has been helpful, but has generated confusion about how to interpret genotype-phenotype discordance. Optimal management is not clearly defined for patients with rifampin resistance by Xpert MTB/RIF but rifampin susceptibility by phenotypic testing. To resolve this discrepancy, we performed pyrosequencing of discordant isolates identified at a reference laboratory over a 6-month period. We present here strategies to address genotype-phenotype discordance using sequencing.

KW - Culture

KW - Discrepancy

KW - Pyrosequencing

KW - Xpert

UR - http://www.scopus.com/inward/record.url?scp=85042715724&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85042715724&partnerID=8YFLogxK

U2 - 10.4103/lungindia.lungindia_71_17

DO - 10.4103/lungindia.lungindia_71_17

M3 - Article

C2 - 29487256

AN - SCOPUS:85042715724

VL - 35

SP - 168

EP - 170

JO - Lung India

JF - Lung India

SN - 0970-2113

IS - 2

ER -